In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for reducing cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight with at least one weight-related comorbidity, based on the SELECT trial
Pharmacists should be aware of various causes of weight gain in midlife women, as well as pharmacotherapies, supplements, and OTC products that either could lead to weight gain or could assist with weight loss
GLP-1 RAs continue to be a cornerstone of antidiabetic therapy but should not be misconstrued as a panacea
Glutathione is the chief detoxification molecule of the body
Ask: Is my skin better, same, or worse than when I started
Low blood glutathione levels in healthy aging adults